Nutriband (NTRB) and The Competition Head-To-Head Survey

Nutriband (OTCMKTS: NTRB) is one of 42 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Nutriband to related companies based on the strength of its profitability, institutional ownership, risk, analyst recommendations, dividends, valuation and earnings.

Institutional and Insider Ownership

45.8% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 46.1% of Nutriband shares are held by insiders. Comparatively, 8.3% of shares of all “Surgical appliances & supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Nutriband and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutriband 0 0 0 0 N/A
Nutriband Competitors 380 1258 2038 107 2.49

As a group, “Surgical appliances & supplies” companies have a potential downside of 1.53%. Given Nutriband’s competitors higher probable upside, analysts clearly believe Nutriband has less favorable growth aspects than its competitors.

Valuation & Earnings

This table compares Nutriband and its competitors gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Nutriband $370,000.00 N/A -31.11
Nutriband Competitors $1.12 billion $151.86 million 35.83

Nutriband’s competitors have higher revenue and earnings than Nutriband. Nutriband is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.


This table compares Nutriband and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nutriband N/A N/A N/A
Nutriband Competitors -206.71% -73.11% -31.46%

About Nutriband

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. Its product line consists of an energy patch line; a weight management patch line; a multivitamin patch line; a children's multivitamin patch line; an amino acid patch line; an anti-wrinkle patch line; an insect repellant patch line; a detox patch line; a PMS patch line; a sleep patch line; and a nausea and motion sickness patch line. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with's FREE daily email newsletter.